This panel discussion brings together key perspectives on the interplay between heart, metabolic, and renal health, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations are reshaping outcomes in patients with diabetes and associated co-morbidities. The session focuses on real-world evidence, patient selection, cardio-renal protection, and practical treatment strategies to achieve comprehensive cardio-renal-metabolic benefits in routine clinical practice.

Hearts, Hormones & Kidneys: Revolutionizing Cardio-Renal-Metabolic Wins with SGLT2i DPP4i combinations

The Cardio-Renal-Metabolic (CRM) Grand Rounds, is a specialized medical conference focused on the latest advancements in managing cardio-renal-metabolic conditions. The event brings together renowned experts in nephrology, endocrinology, and cardiology to discuss cutting-edge research, innovative treatment strategies, and multidisciplinary approaches to patient care. Attendees will gain insights into the evolving landscape of cardio-renal-metabolic health and practical knowledge to enhance patient outcomes.

Cardio-Renal-Metabolic Grand Rounds - Special Room

Cardio-Renal-Metabolic Grand Rounds

Chairman – Nephrology & Kidney Transplant, Epitome Hospital, New Delhi 

This comprehensive session focuses on simplifying type 2 diabetes management through practical insights on DPP-4 inhibitors, with a special emphasis on linagliptin and its role across the disease trajectory. The discussion covers patient selection, renal considerations, cardiovascular safety, long-term glycemic durability, and real-world positioning in diverse clinical scenarios. A clinically oriented update designed to support confident, individualized diabetes care in everyday practice.

Dr. Vijay Kher

4

1.7k

36.4k

4.8

Upcoming Sessions

Sessions Taken

1.4k

4.8

524

0

556

4.7